Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine.
Rabies infections in swine have been reported occasionally in recent years in certain geographic locations. Although a protective vaccine consisting of inactivated rabies virus is available for use in swine, searching for a more economically viable formulation for use in developing countries is always a priority. This work describes the testing of a canine adenovirus that expresses a rabies viral epitope (CAV-2-E3Delta-RGP) in a porcine rabies model. The data presented here show that the recombinant viral vaccine was effective in protecting swine against rabies if administered intramuscularly, but not orally or intranasally, and that protection was probably related to the development of a humoral response that lasted at least 28 weeks. Following vaccination, no behavioral abnormalities were observed in vaccinated swine and virus particles were not detected in either tissues or body fluids, indicating that this formulation was safe. The recombinant virus stimulated an effective level of antibody response in the immunized swine after a single intramuscular inoculation.
Liu
Ye
Y
Laboratory of Epidemiology, Veterinary Institute, Academy of Military Medical Science, 1068 Qinglong Road, Changchun, PR China.
Zhang
Shoufeng
S
Ma
Guangpeng
G
Zhang
Fei
F
Hu
Rongliang
R
D006516:Adenoviruses, Canine / Q000235:genetics / Q000276:immunology*; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D000939:Epitopes / Q000276:immunology; D005260:Female; D005822:Genetic Vectors; D007273:Injections, Intramuscular; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009500:Neutralization Tests; D011818:Rabies / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy / Q000662:veterinary; D011819:Rabies Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D011820:Rabies virus / Q000276:immunology*; D013552:Swine / Q000276:immunology / Q000821:virology*; D013553:Swine Diseases / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy
D000914:Antibodies, Viral; D000939:Epitopes; D011819:Rabies Vaccines